Can hydroxyzine cause elevated liver enzymes, and should the medication be discontinued if liver tests become abnormal?

Hydroxyzine and Elevated Liver Tests

Hydroxyzine is not known to cause hepatotoxicity and is not contraindicated in patients with liver disease, though its elimination is significantly prolonged in patients with hepatic dysfunction, requiring dose reduction. The FDA drug label for hydroxyzine does not list hepatotoxicity as a known adverse effect, and there is no evidence in the medical literature linking hydroxyzine to elevated liver enzymes 1.

Key Clinical Points

Hydroxyzine's Hepatic Safety Profile

• No documented hepatotoxicity: Unlike many medications that require liver monitoring, hydroxyzine does not appear on lists of hepatotoxic drugs and the FDA label contains no warnings about liver injury 1

• Metabolism considerations: Hydroxyzine is metabolized to cetirizine, and while the extent of renal excretion has not been fully determined, the drug is primarily hepatically metabolized 1

Use in Patients with Liver Disease

Hydroxyzine can be used in patients with existing liver disease, but requires significant dose adjustments. Research demonstrates that in patients with primary biliary cirrhosis, hydroxyzine elimination is substantially impaired 2:

• The serum elimination half-life extends to 36.6 hours (compared to normal)
• Peak levels are higher and persist longer
• Clearance is reduced to 8.65 mL/min/kg

Critical caveat: One case report documented a patient with cirrhosis and minimal hepatic encephalopathy who developed acute encephalopathy after hydroxyzine use, which reversed upon drug cessation 3. This occurred due to the drug's CNS depressant effects in the context of existing hepatic dysfunction, not from hepatotoxicity itself.

When Liver Tests Are Elevated

If a patient on hydroxyzine develops elevated liver enzymes, hydroxyzine is unlikely to be the cause. The appropriate approach is:

1. Do not automatically discontinue hydroxyzine - it is not a known hepatotoxin

2. Conduct a comprehensive hepatic workup following standard guidelines 4, 5:

   • Review ALL medications, supplements, and herbal products for known hepatotoxins
   • Obtain viral hepatitis serologies (A, B, C, E if indicated)
   • Check for metabolic causes (iron studies, ceruloplasmin if Wilson's suspected)
   • Assess for autoimmune hepatitis (ANA, ASMA, immunoglobulins)
   • Evaluate for non-alcoholic fatty liver disease
   • Obtain imaging (ultrasound initially)

3. Consider the pattern of elevation 4, 5:

   • Hepatocellular pattern (ALT/AST predominant): Consider viral hepatitis, autoimmune hepatitis, NASH, alcohol, other medications
   • Cholestatic pattern (alkaline phosphatase/bilirubin predominant): Consider biliary obstruction, primary biliary cholangitis, drug-induced cholestasis from OTHER medications

Specific Contraindications for Hydroxyzine

Hydroxyzine IS contraindicated in 1:

• Known hypersensitivity to hydroxyzine, cetirizine, or levocetirizine
• Prolonged QT interval
• Early pregnancy (teratogenic in animal studies)

Hydroxyzine requires caution in 1:

• Elderly patients (start low doses due to increased sedation risk)
• Patients with decreased renal function
• Patients with risk factors for QT prolongation
• Patients with hepatic dysfunction (dose reduction required, not contraindicated)

Practical Management Algorithm

If elevated liver tests are discovered in a patient taking hydroxyzine:

1. Assess severity using standard thresholds 4:

   • Mild: ALT/AST <5× ULN
   • Moderate: 5-15× ULN
   • Severe: >15× ULN

2. For mild elevations: Continue hydroxyzine while investigating other causes; repeat testing in 2-4 weeks

3. For moderate-severe elevations or symptomatic patients: Hold ALL potentially hepatotoxic medications (but hydroxyzine is not typically one of them) and pursue urgent workup

4. If hepatic decompensation occurs: Discontinue hydroxyzine due to risk of precipitating encephalopathy from CNS depression, NOT from hepatotoxicity 3

Bottom Line

Hydroxyzine does not cause elevated liver enzymes and should not be reflexively discontinued when abnormal liver tests are found. The drug's primary concern in liver disease is prolonged elimination requiring dose reduction and the potential to worsen hepatic encephalopathy through CNS depression in patients with advanced cirrhosis. If liver tests become abnormal, pursue standard diagnostic evaluation for hepatic dysfunction while recognizing hydroxyzine is an unlikely culprit 1, 2.